Saturday 27 Jul, 2024 09:28 PM
Site map | Locate Us | Login
   Nuvama Wealth Mgmt Q1 PAT jumps 79% YoY to Rs 221 cr    ICICI Bank Q1 PAT rises 15% YoY to Rs 11,059 cr    Punjab & Sind Bank Q1 PAT rises 19% YoY to Rs 181 cr    Bandhan Bank Q1 PAT climbs 47% to Rs 1,063 cr    BHEL receives LOI for Rs 10,000 crore project from Damodar Valley Corporation    Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore    Power Grid Q1 PAT rises 3% YoY to Rs 3,724 cr    IndusInd Bank PAT rises to Rs 2,152 cr in Q1 FY25    Cipla spurts as Q1 PAT rises 18% YoY to Rs 1,178 cr    Shriram Finance soars as Q1 PAT rises 18% YoY    Indus Towers spurts on buyback plan    MMTC Ltd leads losers in 'A' group    Nova Agritech Ltd leads losers in 'B' group    Volumes soar at New India Assurance Company Ltd counter    Piramal Pharma Q1 net loss narrows to Rs 89 crore 
Saravan Stocks
       
IPO Synopsis
Akums Drugs & Pharmaceuticals Ltd
Registered Office: 304 Mohan Place LSC Saraswati,Vihar, Delhi - 110034, Delhi, India.
Phone : +91 11 6904 1000   Fax:
Email :  cs@akums.net  
Website :  www.akums.in
Initial public offer of up to [*] equity shares of face value of Rs. 2 each ("Equity Shares") of Akums Drugs and Pharmaceuticals Limited ("Company" or "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to Rs. [*] crores comprising a fresh issue of up to [*] equity shares aggregating up to Rs. 680.00 crores by the company ("Fresh Issue") and an offer for sale of up to 17,330,435 equity shares aggregating up to Rs. [*] crores ("Offered Shares") by the selling shareholders, comprising up to 1,512,000 equity shares aggregating up to Rs. [*] crores by Sanjeev Jain, up to 1,512,000 equity shares aggregating up to Rs. [*] crores by Sandeep Jain (together the "Promoter Selling Shareholders") and up to 14,306,435 equity shares aggregating up to Rs. [*] crores by Ruby QC Investment Holdings Pte. Ltd. (the "Investor Selling Shareholder") (the promoter selling shareholders and the investor selling shareholder, collectively referred to as the "Selling Shareholders") ("Offer for Sale", together with the fresh issue, the "Offer"). This offer includes a reservation of up to [*] equity shares aggregating up to Rs. 15.00 crores for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer will constitute [*]% and [*]% of its post-offer paid-up equity share capital, respectively. Price Band: Rs. 646 to Rs. 679 per equity share of face value of Rs. 2 each. The floor price is 323 times of tha face value of and tha cap price is 339.50 times of the face value. Bid can be made for a minimum of 22 equity share and in multiples of 22 equity share thereafter. A discount of Rs. 64 per equity share is being offred to eligible employee bidding in the employee reservation portion.
Issue Money Payable On
Opens On Closes On Application Allotment
30-Jul-24 01-Aug-24 646.00-679.00 0.00-0.00
Minimum Application for shares in Nos : 22   Further Multiples of : 22
  Rs Cr Lead Managers to the Issue
Project Cost 0.00 Ambit Pvt Ltd
Project Financed through Current Offer 1799.55  
Post Issue Equity Share Capital 0.00  
Issue Price 646.00  
Projects
Repayment/prepayment of all or certain borrowings of the company and subsidiary Funding incremental working capital requirements of the company
Pursuing inorganic growth initiatives through acquisitions General corporate purposes
Promoted By
Sanjeev Jain
Sandeep Jain
Akums Master Trust
Listing At
BSE
NSE
Registrar to the Issue
No Data Available
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 34210697
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd